Creative Medical Technology Holdings, Inc.
CELZ
$1.98
-$0.16-7.48%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.46% | 28.47% | -41.34% | 0.99% | 72.99% |
| Total Depreciation and Amortization | -11.37% | 27.39% | 27.39% | 27.39% | 10.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 136.95% | 0.00% | 0.00% | 0.00% | -370.65% |
| Change in Net Operating Assets | 41.34% | -86.26% | -39.90% | 103.76% | -108.37% |
| Cash from Operations | -2.88% | 24.45% | -48.91% | 76.65% | 47.23% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -109.93% | 100.00% | 29.44% | 118.47% |
| Cash from Investing | -100.00% | -109.93% | 100.00% | 29.44% | 118.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | 86.70% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,157.45% | 86.70% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 69.24% | -333.96% | 72.21% | 363.37% | 87.97% |